Skip to main content

All CGMs are Not Created Equal

Not all CGMs are the Same

With several types of CGMs available, knowing the differences between each product can help you recommend the best CGM option for your patients. 

Flash
Flash Glucose Monitoring*

Users must scan sensor to see glucose readings

No alarms and alerts

Self insertions 

Non-removable transmitter

Sensor life - 14 days

Example: Abbott FreeStyle Libre Flash Glucose Monitoring System

real-time
  • Glucose readings every 5 minutes
  • Alarms and alerts to help patients manage their diabetes
  • Self-insertions
  • Non-removable transmitter
  • Sensor life - 7-10 days
  • Warm up period - 2 hours
  • Examples: Dexcom G6, Medtronic Guardian Connect
sensor
  • Glucose readings every 5 minutes
  • Alerts to help patients manage their diabetes
  • Removable transmitter
  • Vibration alerts
  • No self-insertions - Professionally inserted
  • Sensor life - up to 180 days
  • Warm up period - 24 hours
  • Examples: Eversense XL 
Eversense XL

The Benefits of Long-Term CGM

  • Greater insight

    Exceptional accuracy, especially in the 2.2-3.3 mmol/L range.2

    Charts, graphs and in-app reports to improve glycemic awareness.

    Three types of alerts (audio, on body vibe and mobile text) to guide safe management.

     

    Fewer obstacles

    No twice-monthly sensor replacement.

    Near-real time feedback to help predict and monitor trends.

    Detects 95% of hyper/hypo events in 15 minutes.3

     

     

     

    Longer wear time

    92% industry-leading adherence across 3 pivotal trials.1-3

    Fully implantable 180-day sensor.

    Continuous readings and alerts around the clock.

     

    Improved self-management

    Exceptional 59-69% real-world time in target.1

Eversense CGM users report improved confidence and safety.

In a major trial, users reported a high level of satisfaction and reduced distress with the Eversense system. The Eversense XL Continuous Glucose Monitoring System is engineered to overcome many of these barriers by uniquely balancing performance, rich patient insights and a lifestyle-friendly user experience for optimal adherence and outcomes.

Survey Data

*The information and data contained in this table were obtained from each manufacturer’s product user guide: Dexcom (Dexcom G6 CGM System User Guide, 2018); Abbott FreeStyle Libre 14 Day Flash Glucose Monitoring System, Summary of Safety and Effectiveness Data (SSED), July 2018; Medtronic (Guardian Connect System User Guide, 2018); Senseonics (Eversense CGM User Guide, 2018). 

1 Barnard, K. D., Kropff, J., Choudhary, P., Neupane, S., Bain, S. C., Kapitza, C., ... & DeVries, J. H. (2017). Acceptability of Implantable Continuous Glucose Monitoring Sensor. Journal of Diabetes Science and Technology, 1932296817735123. 2 Christiansen MP. PRECISION. Diabetes Technology & Therapeutics. Volume 21, Number 5, 2019. 3 Christiansen MP. PRECISE II. Diabetes Technology & Therapeutics. 2018;20(3):197-206. Kropff J, Choudhary P, Neupane S, et al. PRECISE. Diabetes Care. 2017;40(1):63-68.

MKT-001285 Rev1

No More Self-Insertions for your Patients

Learn how to add Eversense XL to your clinic for optimal patient benefits.

Learn More